Newark, Oct. 16, 2023 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global Active Pharmaceutical Ingredients (API) market is expected to grow from USD 211.0 Billion in ...
Dublin, July 08, 2025 (GLOBE NEWSWIRE) -- The "Veterinary Active Pharmaceutical Ingredients (API) Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added to ...
India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...
Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...
C2 Pharma, which concentrates on hard-to-make ingredients, has picked up a new supply of digoxin. The deal will give it two supplies of API for making the sometimes-difficult-to-get drug. The ...
ANKLESHWAR, India--(BUSINESS WIRE)--RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...
As previously speculated, Teva Pharmaceutical Industries (NYSE:TEVA) will not undergo a split into two separate entities. On Tuesday, Teva’s Chief Executive, Richard Francis, said the company would ...
resilience. pharma& anticipates eligible European patients should start to experience improved Pegasys availability in the coming weeks. “We are thrilled to announce the EMA’s approval for Pegasys API ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback